↓ Skip to main content

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells

Overview of attention for article published in BMC Cancer, January 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
80 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells
Published in
BMC Cancer, January 2008
DOI 10.1186/1471-2407-8-9
Pubmed ID
Authors

Sharon A Glynn, Dermot O'Sullivan, Alex J Eustace, Martin Clynes, Norma O'Donovan

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Denmark 1 1%
France 1 1%
Unknown 77 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 26%
Researcher 16 20%
Student > Bachelor 13 16%
Student > Master 11 14%
Student > Postgraduate 6 8%
Other 10 13%
Unknown 3 4%
Readers by discipline Count As %
Agricultural and Biological Sciences 28 35%
Medicine and Dentistry 21 26%
Biochemistry, Genetics and Molecular Biology 10 13%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Immunology and Microbiology 3 4%
Other 5 6%
Unknown 7 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2016.
All research outputs
#1,190,061
of 4,873,362 outputs
Outputs from BMC Cancer
#398
of 2,736 outputs
Outputs of similar age
#53,600
of 168,395 outputs
Outputs of similar age from BMC Cancer
#36
of 199 outputs
Altmetric has tracked 4,873,362 research outputs across all sources so far. This one has received more attention than most of these and is in the 63rd percentile.
So far Altmetric has tracked 2,736 research outputs from this source. They receive a mean Attention Score of 2.6. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,395 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 199 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.